Search results for "PROSTATE"

showing 10 items of 621 documents

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

2015

Background Gene expression profiling is being widely applied in cancer research to identify biomarkers for clinical endpoint prediction. Since RNA-seq provides a powerful tool for transcriptome-based applications beyond the limitations of microarrays, we sought to systematically evaluate the performance of RNA-seq-based and microarray-based classifiers in this MAQC-III/SEQC study for clinical endpoint prediction using neuroblastoma as a model. Results We generate gene expression profiles from 498 primary neuroblastomas using both RNA-seq and 44 k microarrays. Characterization of the neuroblastoma transcriptome by RNA-seq reveals that more than 48,000 genes and 200,000 transcripts are being …

AdultMaleMicroarrayAdolescentEndpoint DeterminationNEUROBLASTOMA PATIENTSgenetic processesRNA-SeqBiologyBioinformaticsRISK STRATIFICATIONTranscriptomeNeuroblastomaYoung AdultREPRODUCIBILITYClinical endpointTumor Cells CulturedBREAST-CANCERHumansnatural sciencesTRANSCRIPTOMEChildGENE-EXPRESSIONOligonucleotide Array Sequence AnalysisSettore BIO/11 - BIOLOGIA MOLECOLAREEXPRESSION-BASED CLASSIFICATIONModels GeneticSequence Analysis RNAGene Expression ProfilingResearchSIGNATUREInfant NewbornBiology and Life SciencesInfantHuman genetics3. Good healthPROSTATE-CANCERGene expression profilingDIFFERENTIATIONChild PreschoolEndpoint DeterminationFemaleDNA microarray
researchProduct

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

2018

The reporting of osteonecrosis of the jaw (ONJ) related to anticancer agents without known antiresorptive properties (non-antiresorptives), such as antiangiogenics, tyrosine kinase inhibitors, mammalian target of rapamycin inhibitors, immune checkpoint inhibitors, and cytotoxic chemotherapy is increasing. To review characteristics of ONJ in cancer patients receiving non-antiresorptives. A systematic review of the literature between 2009 and 2017 was conducted by the Bone Study Group of MASCC/ISOO. Of 6249 articles reviewed and from personal communication, 42 ONJ cases related to non-antiresorptives were identified. No gender predilection was noted. Median age was 60 years and ONJ stage 2 wa…

AdultMaleOncologyBRAF inhibitormedicine.medical_specialtymTOR inhibitorsImmune checkpoint inhibitorsInhibitors of angiogenesiTyrosine kinase inhibitorBone resorptionImmune checkpoint inhibitorDelayed diagnosisCytotoxic chemotherapyBone resorption03 medical and health sciences0302 clinical medicineProstateInternal medicinemedicineHumans030212 general & internal medicineStage (cooking)AgedBone Density Conservation AgentsDiphosphonatesOsteonecrosis of the jawbusiness.industryOsteonecrosisCancerMiddle AgedCytotoxic chemotherapymedicine.diseasemedicine.anatomical_structureJawOncology030220 oncology & carcinogenesisBisphosphonate-Associated Osteonecrosis of the JawFemaleOsteonecrosis of the jawbusiness
researchProduct

Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers

2019

Background The identification of appropriate biomarkers is essential to support important clinical decisions in patients with prostate cancer. The aim of our study was a systematic bioinformatical analysis of the mRNA expression of all genes available for the prostate adenocarcinoma cohort of The Cancer Genome Atlas (TCGA), regarding their potential prognostic and diagnostic role. Methods The study cohort comprises 499 patients (TCGA prostate cancer cohort). mRNA expression data were available for approx. 20,000 genes. The bioinformatical statistical pipeline addressed gene expression differences in tumor vs. benign prostate tissue (including gene set enrichment analysis, GSEA) in samples f…

AdultMaleOncologyBiochemical recurrencemedicine.medical_specialtyBiomedical ResearchMultivariate analysisBioinformaticsUrology030232 urology & nephrologyAdenocarcinomalcsh:RC870-923PrognosticCohort Studies03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicineBiomarkers TumormedicineHumansDiagnosticEpigeneticsAgedProstate cancerProportional hazards modelbusiness.industryHazard ratiomRNA expressionProstatic NeoplasmsGeneral MedicineMiddle Agedlcsh:Diseases of the genitourinary system. UrologyPrognosismedicine.diseaseGene Expression Regulation NeoplasticReproductive Medicine030220 oncology & carcinogenesisCohortBiomarker (medicine)businessBiomarkersResearch ArticleBMC Urology
researchProduct

PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme

2017

Objectives: PCA3 performance as a single second line biomarker is compared to the European Randomised Study of Screening for Prostate Cancer risk calculator model 3 (ERSPC RC-3) in an opportunistic screening in prostate cancer (PCa). Material and methods: 5,199 men, aged 40-75y, underwent prostate-specific antigen (PSA) screening and digital rectal examination (DRE). Men with a normal DRE and PSA >= 3 ng/ml had a PCA3 test done. All men with PCA3 >= 35 underwent an initial biopsy (IBx) 12 cores. Men with PCA3 = 3 ng/ml and DRE is normal, IBx could be avoided in 12.5% less than if ERSPC RC-3 is used and would reduce the false negative cases by 36.2%. At a FU of 21.7 months, this dual protoco…

AdultMalePCA3medicine.medical_specialty030232 urology & nephrologyUrologyurologic and male genital diseaseslaw.inventionOpportunistic screening03 medical and health sciencesProstate cancerPSA0302 clinical medicineSecond lineRandomized controlled trialAntigens NeoplasmlawBiopsyBiomarkers TumormedicineHumansProspective StudiesEarly Detection of CancerAgedGynecologyProstate cancermedicine.diagnostic_testbusiness.industryProstatic NeoplasmsGeneral MedicineRectal examinationMiddle Agedmedicine.diseaseProstate cancer screening030220 oncology & carcinogenesisBiomarker (medicine)PCA3business
researchProduct

The impact of prior TURP on radical prostatectomy surgical margins: A multicenter analysis and members of the mirror study, LUNA foundation

2013

Objective: To analyze positive surgical margins (PSM) after radical prostatectomy (RP) in the overall population and in patients previously treated with transurethral resection of the prostate (TURP). Materials and Methods: 2,408 patients treated with RP for clinically localized prostate cancer (PCa) were consecutively enrolled in 135 departments. We correlated PSM rates and all preoperative, surgical and pathological features. We stratified the site of PSM as unique or multifocal. Moreover, we analyzed differences between 75 patients who had undergone previous TURP and the remaining 2,333 patients. Results: In the entire study population, we identified 702 patients with PSM (29%). Using un…

AdultMaleRiskPrognosiBiopsyUrologyUrinary BladderPositive surgical marginurologic and male genital diseasesAgedAged 80 and overProstatectomyProstate cancerfungiProstateTransurethral Resection of ProstateMiddle AgedProstate-Specific AntigenRadical prostatectomyTransurethral prostate resectionPositive surgical margins; Prostate cancer; Radical prostatectomy; Transurethral prostate resection; Adult; Aged; Aged 80 and over; Biopsy; Humans; Italy; Male; Middle Aged; Neoplasm Grading; Prognosis; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Risk; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder; UrologyTreatment OutcomeItalyProstatic NeoplasmNeoplasm GradingHuman
researchProduct

Can side-specific biopsy findings predict the side of nodal metastasis in clinically localized prostate cancer? Results from a multicenter prospectiv…

2013

Background To evaluate the correlation between the side of positive biopsy (Bx) and the risk of lymph-node metastases (LNMs) on each side and to quantify the risk of contralateral LNMs in patients with unilateral positive biopsy. Methods We analyzed the outcomes of 1599 patients with complete data regarding the sides of positive Bx and LN (lymph-node). By dividing each prostate into two separate sides, we assessed the accuracy of the side-specific Bx details in determining the side of positive nodes; the area under the receiver-operating characteristic (ROC) (AUCs) was used. For patients with unilateral positive Bx, we assessed the risk of homolateral and contralateral LNMs according to the…

AdultMaleRiskmedicine.medical_specialtyProstate biopsyPelviLymph node metastasis; Pelvic lymph node dissection; Prostate biopsy; Prostate cancer; Radical prostatectomyPelvisProstate biopsyProstate cancerLymph node metastasiProstateBiopsymedicineHumansProspective StudiesProspective surveyAgedAged 80 and overProstatectomyLymph node metastasisProstate cancermedicine.diagnostic_testbusiness.industryNodal metastasisProstatic NeoplasmsLymph NodeLymphatic MetastasiGeneral MedicineMiddle Agedmedicine.diseaseRadical prostatectomySurgeryPelvic lymph node dissectionDissectionProspective Studiemedicine.anatomical_structureROC CurveOncologyLymphatic MetastasisProstatic NeoplasmLymph Node ExcisionSurgeryRadiologyLymph NodesBiopsy Large-Core NeedlebusinessBiopsy findingsHuman
researchProduct

Regional distribution of opioidergic nerves in human and canine prostates

1989

The regional distribution of opioidergic nerves in the juvenile and adult human prostate and in the adult canine prostate has been studied immunohistochemically using well-characterized polyclonal antisera against multiple opioid peptides. Nerves displaying immunoreactivity (ir) for the proenkephalin (PRO-ENK) derivatives met-enkephalin (ME), leuenkephalin (LE), octapeptide, and heptapeptide (ordered in decreasing frequency) were present in the dorsolateral stroma of human prostate. In canine prostate, the situation was similar, but the number of opioid-ir nerve fibers was lower than in human prostate. In both species, staining for the prodynorphin (PRO-DYN) derivatives dynorphin A and alph…

AdultMaleendocrine systemmedicine.medical_specialtyStromal cellAdolescentEnkephalin MethionineUrologyDynorphinBiologyEjaculatory ductchemistry.chemical_compoundDogsProstateInternal medicinemedicineAnimalsHumansOpioid peptideAgedEndogenous opioidProstateInfantDynorphin AMiddle AgedImmunohistochemistryPeptide FragmentsProenkephalinEndocrinologymedicine.anatomical_structureOncologychemistryChild PreschoolEnkephalin LeucineThe Prostate
researchProduct

Prevalence and clinical significance of incidental findings on multiparametric prostate MRI.

2019

Purpose: To assess the prevalence and clinical significance of incidental findings (IFs) detected at multiparametric prostate MRI examination. Materials and methods: Multiparametric prostate MRIs of 647 consecutive patients (mean age 67.1 ± 8.0 years) were retrospectively evaluated by two radiologists recording the presence of all extra-prostatic IFs. Findings were classified as related to or not related to genitourinary system and divided into three classes, according to their clinical significance, as follows: group 1, not significant or scarcely significant; group 2, moderately or potentially significant; and group 3, significant. Differences in distribution of IFs between patients ≤ 65 …

AdultMalemedicine.medical_specialty030218 nuclear medicine & medical imagingCollateral findings03 medical and health sciencesProstate cancer0302 clinical medicineProstateStatistical significancePrevalenceMedicineHumansRadiology Nuclear Medicine and imagingClinical significanceAgedRetrospective StudiesAged 80 and overIncidental FindingsProstate cancermedicine.diagnostic_testbusiness.industryGenitourinary systemProstatic NeoplasmsMagnetic resonance imagingRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance ImagingExact testmedicine.anatomical_structure030220 oncology & carcinogenesisRadiologybusinessLa Radiologia medica
researchProduct

100 cases of Mainz pouch: continuing experience and evolution.

1988

The surgical technique for creation of the Mainz pouch uses 10 to 15 cm. of cecum and ascending colon and 2 ileal loops of the same length for construction of a urinary reservoir. Initial applications of the Mainz pouch were for bladder augmentation after subtotal cystectomy and for continent urinary diversion. Current indications have been extended to complete bladder substitution after radical cystoprostatectomy with anastomosis of the pouch to the membranous urethra. For cosmetic reasons the umbilicus is used as a stomal site for continent urinary diversion, and the technique of intussuscepting the continence nipple has been modified accordingly. A total of 100 patients underwent a Mainz…

AdultMalemedicine.medical_specialtyAdolescentMembranous urethraColonUrologymedicine.medical_treatmentUrinary BladderAnastomosisUrinary DiversionCystoprostatectomyCystectomyPostoperative ComplicationsIleumMedicineAscending colonHumansChildCecumAgedProstatectomyIleocecal Valvebusiness.industryMiddle AgedSurgerymedicine.anatomical_structureUrinary IncontinenceBladder augmentationPouchbusinessContinent Urinary DiversionFollow-Up StudiesThe Journal of urology
researchProduct

Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey

2018

Introduction: The urological community's opinion over focal therapy (FT) for prostate cancer (PCa) has never been assessed. Our aim was to investigate the current opinion on FT in the European urological community. Methods: A 25 -item questionnaire was devised according to the Cherries checklist and distributed through SurveyMonkey using a web link from November 2016 to October 2017. After a pilot validation (n=40 urologists), the survey was sent through EAU and 9 other national European urological societies mailing list. Twitter was also used. Results: We received 484 replies from 51 countries. Almost half (44.8%, n=217) stated FT would represent a step forward, and 52.0% (n=252) would sug…

AdultMalemedicine.medical_specialtyMultivariate analysisUrology030232 urology & nephrologyClinical practiceClinical practice; European Association of Urology; Focal therapy; Prostate cancer; Survey; Young Academic Urologists03 medical and health sciencesProstate cancer0302 clinical medicineFocal therapySurveys and QuestionnairesmedicineHumansIn patientSurveyProstate cancerbusiness.industryProstatic NeoplasmsNegative opinionMiddle AgedUrology & NephrologyPrognosismedicine.diseaseChecklistEuropeFocal therapyClinical PracticeEuropean Association of UrologyYoung Academic UrologistsCross-Sectional StudiesOncology030220 oncology & carcinogenesisFamily medicineEAU-YAU Prostate Cancer Working Partybusiness1112 Oncology And CarcinogenesisFollow-Up StudiesUrologic Oncology: Seminars and Original Investigations
researchProduct